Efficacy and Safety of MOX/ALB vs. IVM/ALB Co-administration
Clinical trial NCT04700423 · COMPLETED
Trial details
- NCT number
- NCT04700423
- Sponsor
- Jennifer Keiser
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-01
- Primary completion
- 2021-08-18
- Enrollment
- 536
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.